Design and evaluation of cyclodextrin-based drug formulation

被引:277
作者
Uekama, K [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan
关键词
cyclodextrin derivative; inclusion complex; cyclodextrin/drug conjugate; absorption enhancement; controlled drug release; site-specific drug delivery;
D O I
10.1248/cpb.52.900
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The pharmaceutically useful cyclodextrins (CyDs) are classified into hydrophilic, hydrophobic, and ionic derivatives. Because of the multi-functional characteristics and bioadaptability, these CyDs are capable of alleviating the undesirable properties of drug molecules through the formation of inclusion complexes or the form of CyD/drug conjugates. This review outlines the current application of CyDs in design and evaluation of CyD-based drug formulation, focusing on their ability to enhance the drug absorption across biological barriers, the ability to control the rate and time profiles of drug release, and the ability to deliver a drug to a targeted site.
引用
收藏
页码:900 / 915
页数:16
相关论文
共 174 条
[1]   COMBINED USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN AND A LIPOPHILIC ABSORPTION ENHANCER IN NASAL DELIVERY OF THE LHRH AGONIST, BUSERELIN ACETATE, IN RATS [J].
ABE, K ;
IRIE, T ;
ADACHI, H ;
UEKAMA, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 123 (01) :103-112
[2]  
Abe K, 1995, CHEM PHARM BULL, V43, P2232
[3]   COMBINATION EFFECTS OF O-CARBOXYMETHYL-O-ETHYL-BETA-CYCLODEXTRIN AND PENETRATION ENHANCER HPE-101 ON TRANSDERMAL DELIVERY OF PROSTAGLANDIN-E(1) IN HAIRLESS MICE [J].
ADACHI, H ;
IRIE, T ;
UEKAMA, K ;
MANAKO, T ;
YANO, T ;
SAITA, M .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 1 (03) :117-123
[4]  
AIRMA H, 2002, RECENT RES DEV CHEM, V2, P55
[5]   Effect of peracylation of β-cyclodextrin on the molecular structure and on the formation of inclusion complexes:: An X-ray study [J].
Añibarro, M ;
Gessler, K ;
Usón, I ;
Sheldrick, GM ;
Harata, K ;
Uekama, K ;
Hirayama, F ;
Abe, Y ;
Saenger, W .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (48) :11854-11862
[6]  
[Anonymous], COMPREHENSIVE SUPRAM
[7]  
[Anonymous], 1994, DRUG TARG D
[8]   Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-β-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers [J].
Arima, H ;
Yunomae, K ;
Morikawa, T ;
Hirayama, F ;
Uekama, K .
PHARMACEUTICAL RESEARCH, 2004, 21 (04) :625-634
[9]   ENHANCED RECTAL ABSORPTION AND REDUCED LOCAL IRRITATION OF THE ANTIINFLAMMATORY DRUG ETHYL 4-BIPHENYLYLACETATE IN RATS BY COMPLEXATION WITH WATER-SOLUBLE BETA-CYCLODEXTRIN DERIVATIVES AND FORMULATION AS OLEAGINOUS SUPPOSITORY [J].
ARIMA, H ;
KONDO, T ;
IRIE, T ;
UEKAMA, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (11) :1119-1125
[10]   Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats [J].
Arima, H ;
Yunomae, K ;
Miyake, K ;
Irie, T ;
Hirayama, F ;
Uekama, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (06) :690-701